Ali, Bassam R.

SRD5A3 Is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder

Cantagrel, V., Lefeber, D. J., Ng, B. G., Guan, Z., Silhavy, J. L., Bielas, S. L., Lehle, L., Hombauer, H., Adamowicz, M., Swiezewska, E., et al. (2010) · Cell

Glycosylation and Glycoproteins ResearchGlycogen Storage Diseases and Myoclonus

Cited by 309

Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells

Sasidharan Nair, V., Toor, S. M., Ali, B. R., & Elkord, E. (2018) · Expert Opinion on Therapeutic Targets

Cancer Immunotherapy and BiomarkersCytokine Signaling Pathways and Interactions

Cited by 159

Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials

Arnone, D., Omar, O., Arora, T., Östlundh, L., Ramaraj, R., Javaid, S., Govender, R. D., Ali, B. R., Patrinos, G. P., Young, A. H., et al. (2023) · Neuroscience & Biobehavioral Reviews

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 53

Delineation of the Clinical, Molecular and Cellular Aspects of Novel JAM 3 Mutations Underlying the Autosomal Recessive Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts

Akawi, N. A., Canpolat, F. E., White, S. M., Quilis‐Esquerra, J., Morales Sanchez, M., Gamundi, M. J., Mochida, G. H., Walsh, C. A., Ali, B. R., & Al‐Gazali, L. (2013) · Human Mutation

Barrier Structure and Function StudiesGenomics and Rare Diseases

Cited by 47